Treatment Advances and Management of ES-SCLC
 |
| Treatment Advances and Management of ES-SCLC Panelists discuss the current treatment landscape of ES-SCLC, review recent clinical trials, and how they prepare their sites for tarlatamab administration, patient monitoring and management of adverse events Watch Now |
|
Featured Video |
 |
| Institutional Implementation: Setting Up Tarlatamab Administration Panelists discuss how the administration of tarlatamab requires thorough pretreatment screening, staff training, and close monitoring for immune-related adverse effects such as cytokine release syndrome, emphasizing the importance of patient education, rapid intervention, and specialized infrastructure for safe and effective treatment. Watch Now |